1 Study Coverage 1.1 Transthyretin Amyloidosis (ATTR) Revenue in Transthyretin Amyloidosis (ATTR) Business (2017-2022) & (US$ Million) Introduction 1.2 Global Transthyretin Amyloidosis (ATTR) Outlook 2017 VS 2022 VS 2028 1.2.1 Global Transthyretin Amyloidosis (ATTR) Market Size for the Year 2017-2028 1.2.2 Global Transthyretin Amyloidosis (ATTR) Market Size for the Year 2017-2028 1.3 Transthyretin Amyloidosis (ATTR) Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States Transthyretin Amyloidosis (ATTR) in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of Transthyretin Amyloidosis (ATTR) Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 Transthyretin Amyloidosis (ATTR) Market Dynamics 1.4.1 Transthyretin Amyloidosis (ATTR) Industry Trends 1.4.2 Transthyretin Amyloidosis (ATTR) Market Drivers 1.4.3 Transthyretin Amyloidosis (ATTR) Market Challenges 1.4.4 Transthyretin Amyloidosis (ATTR) Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 Transthyretin Amyloidosis (ATTR) by Type 2.1 Transthyretin Amyloidosis (ATTR) Market Segment by Type 2.1.1 Hereditary ATTR (HATTR) 2.1.2 Wild-Type (WT) ATTR 2.2 Global Transthyretin Amyloidosis (ATTR) Market Size by Type (2017, 2022 & 2028) 2.3 Global Transthyretin Amyloidosis (ATTR) Market Size by Type (2017-2028) 2.4 United States Transthyretin Amyloidosis (ATTR) Market Size by Type (2017, 2022 & 2028) 2.5 United States Transthyretin Amyloidosis (ATTR) Market Size by Type (2017-2028) 3 Transthyretin Amyloidosis (ATTR) by Application 3.1 Transthyretin Amyloidosis (ATTR) Market Segment by Application 3.1.1 Hospitals 3.1.2 Ambulatory Surgical Centers 3.1.3 Diagnostic Centers 3.2 Global Transthyretin Amyloidosis (ATTR) Market Size by Application (2017, 2022 & 2028) 3.3 Global Transthyretin Amyloidosis (ATTR) Market Size by Application (2017-2028) 3.4 United States Transthyretin Amyloidosis (ATTR) Market Size by Application (2017, 2022 & 2028) 3.5 United States Transthyretin Amyloidosis (ATTR) Market Size by Application (2017-2028) 4 Global Transthyretin Amyloidosis (ATTR) Competitor Landscape by Company 4.1 Global Transthyretin Amyloidosis (ATTR) Market Size by Company 4.1.1 Top Global Transthyretin Amyloidosis (ATTR) Companies Ranked by Revenue (2021) 4.1.2 Global Transthyretin Amyloidosis (ATTR) Revenue by Player (2017-2022) 4.2 Global Transthyretin Amyloidosis (ATTR) Concentration Ratio (CR) 4.2.1 Transthyretin Amyloidosis (ATTR) Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of Transthyretin Amyloidosis (ATTR) in 2021 4.2.3 Global Transthyretin Amyloidosis (ATTR) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Transthyretin Amyloidosis (ATTR) Headquarters, Revenue in Transthyretin Amyloidosis (ATTR) Business (2017-2022) & (US$ Million) Type 4.3.1 Global Transthyretin Amyloidosis (ATTR) Headquarters and Area Served 4.3.2 Global Transthyretin Amyloidosis (ATTR) Companies Revenue in Transthyretin Amyloidosis (ATTR) Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into Transthyretin Amyloidosis (ATTR) Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States Transthyretin Amyloidosis (ATTR) Market Size by Company 4.5.1 Top Transthyretin Amyloidosis (ATTR) Players in United States, Ranked by Revenue (2021) 4.5.2 United States Transthyretin Amyloidosis (ATTR) Revenue by Players (2020, 2021 & 2022) 5 Global Transthyretin Amyloidosis (ATTR) Market Size by Region 5.1 Global Transthyretin Amyloidosis (ATTR) Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Transthyretin Amyloidosis (ATTR) Market Size by Region (2017-2028) 5.2.1 Global Transthyretin Amyloidosis (ATTR) Market Size by Region: 2017-2022 5.2.2 Global Transthyretin Amyloidosis (ATTR) Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Transthyretin Amyloidosis (ATTR) Market Size YoY Growth 2017-2028 6.1.2 North America Transthyretin Amyloidosis (ATTR) Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Transthyretin Amyloidosis (ATTR) Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Transthyretin Amyloidosis (ATTR) Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Transthyretin Amyloidosis (ATTR) Market Size YoY Growth 2017-2028 6.3.2 Europe Transthyretin Amyloidosis (ATTR) Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Transthyretin Amyloidosis (ATTR) Market Size YoY Growth 2017-2028 6.4.2 Latin America Transthyretin Amyloidosis (ATTR) Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Transthyretin Amyloidosis (ATTR) Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Transthyretin Amyloidosis (ATTR) Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Pfizer 7.1.1 Pfizer Company Details 7.1.2 Pfizer Business Overview 7.1.3 Pfizer Transthyretin Amyloidosis (ATTR) Introduction 7.1.4 Pfizer Revenue in Transthyretin Amyloidosis (ATTR) Business (2017-2022) 7.1.5 Pfizer Recent Development 7.2 Alnylam Pharmaceuticals 7.2.1 Alnylam Pharmaceuticals Company Details 7.2.2 Alnylam Pharmaceuticals Business Overview 7.2.3 Alnylam Pharmaceuticals Transthyretin Amyloidosis (ATTR) Introduction 7.2.4 Alnylam Pharmaceuticals Revenue in Transthyretin Amyloidosis (ATTR) Business (2017-2022) 7.2.5 Alnylam Pharmaceuticals Recent Development 7.3 Ionis Pharmaceuticals 7.3.1 Ionis Pharmaceuticals Company Details 7.3.2 Ionis Pharmaceuticals Business Overview 7.3.3 Ionis Pharmaceuticals Transthyretin Amyloidosis (ATTR) Introduction 7.3.4 Ionis Pharmaceuticals Revenue in Transthyretin Amyloidosis (ATTR) Business (2017-2022) 7.3.5 Ionis Pharmaceuticals Recent Development 7.4 Corino Therapeutics 7.4.1 Corino Therapeutics Company Details 7.4.2 Corino Therapeutics Business Overview 7.4.3 Corino Therapeutics Transthyretin Amyloidosis (ATTR) Introduction 7.4.4 Corino Therapeutics Revenue in Transthyretin Amyloidosis (ATTR) Business (2017-2022) 7.4.5 Corino Therapeutics Recent Development 7.5 Proclara Bioscience 7.5.1 Proclara Bioscience Company Details 7.5.2 Proclara Bioscience Business Overview 7.5.3 Proclara Bioscience Transthyretin Amyloidosis (ATTR) Introduction 7.5.4 Proclara Bioscience Revenue in Transthyretin Amyloidosis (ATTR) Business (2017-2022) 7.5.5 Proclara Bioscience Recent Development 7.6 Arcturus Therapeutics 7.6.1 Arcturus Therapeutics Company Details 7.6.2 Arcturus Therapeutics Business Overview 7.6.3 Arcturus Therapeutics Transthyretin Amyloidosis (ATTR) Introduction 7.6.4 Arcturus Therapeutics Revenue in Transthyretin Amyloidosis (ATTR) Business (2017-2022) 7.6.5 Arcturus Therapeutics Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer

List of Tables Table 1. Transthyretin Amyloidosis (ATTR) Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. Transthyretin Amyloidosis (ATTR) Market Trends Table 3. Transthyretin Amyloidosis (ATTR) Market Drivers Table 4. Transthyretin Amyloidosis (ATTR) Market Challenges Table 5. Transthyretin Amyloidosis (ATTR) Market Restraints Table 6. Global Transthyretin Amyloidosis (ATTR) Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Transthyretin Amyloidosis (ATTR) Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Transthyretin Amyloidosis (ATTR) Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Transthyretin Amyloidosis (ATTR) Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Transthyretin Amyloidosis (ATTR) Companies in Global Market, Ranking by Revenue (2021) Table 11. Global Transthyretin Amyloidosis (ATTR) Revenue by Player, (US$ Million), 2017-2022 Table 12. Global Transthyretin Amyloidosis (ATTR) Revenue Share by Player, 2017-2022 Table 13. Global Transthyretin Amyloidosis (ATTR) Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global Transthyretin Amyloidosis (ATTR) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Transthyretin Amyloidosis (ATTR) as of 2021) Table 15. Top Players of Transthyretin Amyloidosis (ATTR) in Global Market, Headquarters and Area Served Table 16. Companies Revenue in Transthyretin Amyloidosis (ATTR) Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into Transthyretin Amyloidosis (ATTR) Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top Transthyretin Amyloidosis (ATTR) Players in United States Market, Ranking by Revenue (2021) Table 20. United States Transthyretin Amyloidosis (ATTR) Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States Transthyretin Amyloidosis (ATTR) Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global Transthyretin Amyloidosis (ATTR) Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global Transthyretin Amyloidosis (ATTR) Market Size by Region (2017-2022) & (US$ Million) Table 24. Global Transthyretin Amyloidosis (ATTR) Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America Transthyretin Amyloidosis (ATTR) Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific Transthyretin Amyloidosis (ATTR) Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe Transthyretin Amyloidosis (ATTR) Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa Transthyretin Amyloidosis (ATTR) Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa Transthyretin Amyloidosis (ATTR) Sales in Value by Country (2017-2028) & (US$ Million) Table 30. Pfizer Company Details Table 31. Pfizer Business Overview Table 32. Pfizer Transthyretin Amyloidosis (ATTR) Product Table 33. Pfizer Revenue in Transthyretin Amyloidosis (ATTR) Business (2017-2022) & (US$ Million) Table 34. Pfizer Recent Development Table 35. Alnylam Pharmaceuticals Company Details Table 36. Alnylam Pharmaceuticals Business Overview Table 37. Alnylam Pharmaceuticals Transthyretin Amyloidosis (ATTR) Product Table 38. Alnylam Pharmaceuticals Revenue in Transthyretin Amyloidosis (ATTR) Business (2017-2022) & (US$ Million) Table 39. Alnylam Pharmaceuticals Recent Development Table 40. Ionis Pharmaceuticals Company Details Table 41. Ionis Pharmaceuticals Business Overview Table 42. Ionis Pharmaceuticals Transthyretin Amyloidosis (ATTR) Product Table 43. Ionis Pharmaceuticals Revenue in Transthyretin Amyloidosis (ATTR) Business (2017-2022) & (US$ Million) Table 44. Ionis Pharmaceuticals Recent Development Table 45. Corino Therapeutics Company Details Table 46. Corino Therapeutics Business Overview Table 47. Corino Therapeutics Transthyretin Amyloidosis (ATTR) Product Table 48. Corino Therapeutics Revenue in Transthyretin Amyloidosis (ATTR) Business (2017-2022) & (US$ Million) Table 49. Corino Therapeutics Recent Development Table 50. Proclara Bioscience Company Details Table 51. Proclara Bioscience Business Overview Table 52. Proclara Bioscience Transthyretin Amyloidosis (ATTR) Product Table 53. Proclara Bioscience Revenue in Transthyretin Amyloidosis (ATTR) Business (2017-2022) & (US$ Million) Table 54. Proclara Bioscience Recent Development Table 55. Arcturus Therapeutics Company Details Table 56. Arcturus Therapeutics Business Overview Table 57. Arcturus Therapeutics Transthyretin Amyloidosis (ATTR) Product Table 58. Arcturus Therapeutics Revenue in Transthyretin Amyloidosis (ATTR) Business (2017-2022) & (US$ Million) Table 59. Arcturus Therapeutics Recent Development Table 60. Research Programs/Design for This Report Table 61. Key Data Information from Secondary Sources Table 62. Key Data Information from Primary Sources List of Figures Figure 1. Transthyretin Amyloidosis (ATTR) Product Picture Figure 2. Global Transthyretin Amyloidosis (ATTR) Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Transthyretin Amyloidosis (ATTR) Market Size 2017-2028 (US$ Million) Figure 4. United States Transthyretin Amyloidosis (ATTR) Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States Transthyretin Amyloidosis (ATTR) Market Size 2017-2028 (US$ Million) Figure 6. United States Transthyretin Amyloidosis (ATTR) Market Share in Global 2017-2028 Figure 7. Transthyretin Amyloidosis (ATTR) Report Years Considered Figure 8. Product Picture of Hereditary ATTR (HATTR) Figure 9. Product Picture of Wild-Type (WT) ATTR Figure 10. Global Transthyretin Amyloidosis (ATTR) Market Share by Type in 2022 & 2028 Figure 11. Global Transthyretin Amyloidosis (ATTR) Market Size by Type (2017-2028) & (US$ Million) Figure 12. Global Transthyretin Amyloidosis (ATTR) Market Share by Type (2017-2028) Figure 13. United States Transthyretin Amyloidosis (ATTR) Market Share by Type in 2022 & 2028 Figure 14. United States Transthyretin Amyloidosis (ATTR) Market Size by Type (2017-2028) & (US$ Million) Figure 15. United States Transthyretin Amyloidosis (ATTR) Market Share by Type (2017-2028) Figure 16. Product Picture of Hospitals Figure 17. Product Picture of Ambulatory Surgical Centers Figure 18. Product Picture of Diagnostic Centers Figure 19. Global Transthyretin Amyloidosis (ATTR) Market Share by Application in 2022 & 2028 Figure 20. Global Transthyretin Amyloidosis (ATTR) Market Size by Application (2017-2028) & (US$ Million) Figure 21. Global Transthyretin Amyloidosis (ATTR) Market Share by Application (2017-2028) Figure 22. United States Transthyretin Amyloidosis (ATTR) Market Share by Application in 2022 & 2028 Figure 23. United States Transthyretin Amyloidosis (ATTR) Market Size by Application (2017-2028) & (US$ Million) Figure 24. United States Transthyretin Amyloidosis (ATTR) Market Share by Application (2017-2028) Figure 25. North America Transthyretin Amyloidosis (ATTR) Market Size Growth Rate 2017-2028 (US$ Million) Figure 26. U.S. Transthyretin Amyloidosis (ATTR) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 27. Canada Transthyretin Amyloidosis (ATTR) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 28. Europe Transthyretin Amyloidosis (ATTR) Market Size Growth Rate 2017-2028 (US$ Million) Figure 29. Germany Transthyretin Amyloidosis (ATTR) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 30. France Transthyretin Amyloidosis (ATTR) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 31. U.K. Transthyretin Amyloidosis (ATTR) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 32. Italy Transthyretin Amyloidosis (ATTR) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 33. Russia Transthyretin Amyloidosis (ATTR) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 34. Asia-Pacific Transthyretin Amyloidosis (ATTR) Market Size Growth Rate 2017-2028 (US$ Million) Figure 35. China Transthyretin Amyloidosis (ATTR) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 36. Japan Transthyretin Amyloidosis (ATTR) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 37. South Korea Transthyretin Amyloidosis (ATTR) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 38. India Transthyretin Amyloidosis (ATTR) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 39. Australia Transthyretin Amyloidosis (ATTR) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. Taiwan Transthyretin Amyloidosis (ATTR) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 41. Indonesia Transthyretin Amyloidosis (ATTR) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. Thailand Transthyretin Amyloidosis (ATTR) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. Malaysia Transthyretin Amyloidosis (ATTR) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. Philippines Transthyretin Amyloidosis (ATTR) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 45. Latin America Transthyretin Amyloidosis (ATTR) Market Size Growth Rate 2017-2028 (US$ Million) Figure 46. Mexico Transthyretin Amyloidosis (ATTR) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 47. Brazil Transthyretin Amyloidosis (ATTR) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 48. Argentina Transthyretin Amyloidosis (ATTR) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 49. Middle East & Africa Transthyretin Amyloidosis (ATTR) Market Size Growth Rate 2017-2028 (US$ Million) Figure 50. Turkey Transthyretin Amyloidosis (ATTR) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 51. Saudi Arabia Transthyretin Amyloidosis (ATTR) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 52. U.A.E Transthyretin Amyloidosis (ATTR) Market Size Growth Rate (2017-2028) & (US$ Million) Figure 53. Pfizer Revenue Growth Rate in Transthyretin Amyloidosis (ATTR) Business (2017-2022) Figure 54. Alnylam Pharmaceuticals Revenue Growth Rate in Transthyretin Amyloidosis (ATTR) Business (2017-2022) Figure 55. Ionis Pharmaceuticals Revenue Growth Rate in Transthyretin Amyloidosis (ATTR) Business (2017-2022) Figure 56. Corino Therapeutics Revenue Growth Rate in Transthyretin Amyloidosis (ATTR) Business (2017-2022) Figure 57. Proclara Bioscience Revenue Growth Rate in Transthyretin Amyloidosis (ATTR) Business (2017-2022) Figure 58. Arcturus Therapeutics Revenue Growth Rate in Transthyretin Amyloidosis (ATTR) Business (2017-2022) Figure 59. Bottom-up and Top-down Approaches for This Report Figure 60. Data Triangulation Figure 61. Key Executives Interviewed

Pfizer Alnylam Pharmaceuticals Ionis Pharmaceuticals Corino Therapeutics Proclara Bioscience Arcturus Therapeutics